Paediatric asthma exacerbations are often caused by rhinovirus (RV). Moreover, 25(OH)-vitamin D3 (VitD3) deficiency during infancy was found associated with asthma. Here, we investigated the innate immune responses to RV and their possible modulation by 25(OH)-VitD3 serum levels in a preschool cohort of children with and without asthma. The innate lymphoid cell type 2 (ILC2)-associated marker, ST2, was found up-regulated in the blood cells of asthmatic children with low serum levels of 25(OH)-VitD3 in the absence of RV in their airways. Furthermore, in blood cells from control and asthmatic children with RV in their airways, soluble (s) ST2 (sST2) protein was found reduced. Asthmatic children with low 25(OH)-VitD3 in serum and with RV in vivo in their airways at the time of the analysis had the lowest sST2 protein levels in the peripheral blood compared to control children without RV and high levels of 25(OH)-VitD3. Amphiregulin (AREG), another ILC2-associated marker, was found induced in the control children with RV in their airways and low serum levels of 25(OH)-VitD3. In conclusion, the anti-inflammatory soluble form of ST2, also known as sST2, in serum correlated directly with interleukin (IL)-33 in the airways of asthmatic children. Furthermore, RV colonization in the airways and low serum levels of 25(OH)-VitD3 were found to be associated with downregulation of sST2 in serum in paediatric asthma. These data indicate a counter-regulatory role of 25(OH)-VitD3 on RV-induced down-regulation of serum sST2 in paediatric asthma, which is relevant for the therapy of this disease.
Introduction
Allergic asthma is an increasingly common chronic inflammatory disease of the airways that affects millions of people worldwide [1] .
While the classical model of allergy-induced airway inflammation focuses on a T helper type 2 (Th2)-driven immune reaction [2, 3] , recent studies have noted the role of group 2 innate lymphoid cells (ILC2s) in models of allergic asthma [4] [5] [6] . This newly discovered cell population is able to react directly and immediately to an allergeninduced epithelial cell stimulation without the need for antigen presentation [6] . Once stimulated, ILC2s react with the secretion of interleukin (IL)-5, IL-9 and IL-13, known classically as Th2 cytokines [5, 7] . In addition, ILC2s release amphiregulin, a protein belonging to the epidermal growth factor family that has the ability to repair damaged epithelial cells, e.g. after an asthma attack and to promote the growth of normal epithelial cells [8] . Amphiregulin B (AREGB), the gene that encodes amphiregulin, is a known target gene of 25(OH)-vitamin D3 (VitD3) [9] .
As little is known about how ILC2s can be influenced exogenously, in this study we analysed ILC2-associated genes and their regulating factors. During an allergen and rhinovirus (RV)-induced asthma exacerbation in vivo, IL-33 and IL-25 (IL-17E) [10] are released from the infected necrotic airway epithelial cells, leading to the activation of IL-33-responsive IL-33R/ST2
1 T cells in general, and specifically to the activation of ILC2s [11] , which are key effector cells releasing Th2 cytokines such as IL-13 and IL-5, thus linking viral infection and the exacerbation of asthma [12] [13] [14] . ST2 is encoded by IL-1RL1, and after differential gene splicing it can produce a functional membrane-bound receptor (IL-33R or ST2L) or soluble decoy receptor (sST2), depending on the splice variant [15] . Moreover, it has been demonstrated recently that 25(OH)-VitD3 enhances production of the soluble ST2 isoform [16] . Because soluble sST2 neutralizes the effect of IL-33, sST2 is considered an anti-inflammatory factor in asthma [17, 18] .
Thus, IL-33 neutralization may be a novel therapeutic approach for asthma exacerbations [12] .
VitD3, also named cholecalciferol, is a type of VitD found in food and is used as a dietary supplement. Cholecalciferol is synthesized in the skin from 7-dehydrocholesterol under the action of ultraviolet (UV)-B light. Blood levels of this molecule largely reflect the amount of cholecalciferol produced in the skin combined with any VitD2 or D3 ingested. The hydroxylation of VitD3 in the endoplasmic reticulum of liver hepatocytes to calcifediol (25-hydroxycholecalciferol) occurs by means of a 25-hydroxylase. Hydroxylation in the kidneys of calcifediol to calcitriol is induced by a 1-a-hydroxylase (CYP27B1), resulting in the production of the biologically active form 1,25-dihydroxyvitamin D3. As 1,25(OH)-VitD3 is unstable, the detection of 25(OH)-VitD3 is one of the highly discussed therapeutic compounds for allergic asthma [19] . It is known that 25(OH)-VitD3-deficient patients show more asthma exacerbations, longer-lasting disease [20] and increased corticosteroid use [21] . Moreover, recent studies have demonstrated that 25(OH)-VitD3 supplementation can reduce airway inflammation [22] and inflammatory cell proliferation [23] .
To analyse the reciprocal influence of genes associated with ILC2s in allergy development and the antiinflammatory effect of 25(OH)-VitD3, we focused on the influence of 25(OH)-VitD3 in asthma with a special interest in ST2 [12] , using human blood samples and looking at the immunomodulatory role of serum levels of 25(OH)-VitD3 in asthma, as well as RV-associated asthma, in a paediatric cohort of children.
Materials and methods

Human studies
The present study is part of the prospective study PreDicta (post-infectious immune reprogramming and its association with persistence and chronicity of respiratory allergic diseases). This study was performed on the WP1-cohort set up at the Department of Molecular Pneumology in Erlangen in collaboration with the local Children's Hospital. The study in Erlangen was approved by the Ethics Committee of the Universit€ ats-klinikum FriedrichAlexander Universit€ at Erlangen-N€ urnberg (Re-no 4435), and is registered in the German Clinical Trials Register (www.germanctr.de: DRKS00004914). Parents/guardians of all participants gave their informed consent. All methods in this study were performed in accordance with the relevant guidelines and regulations Two cohorts of preschool children (aged 4-6 years) with and without asthma were analysed. The recruitment of the subjects, inclusion and exclusion criteria, as well as the time-scale for clinical visits and data collection, have been described recently [24] [25] [26] , and patient characteristics are reported in Table 1 .
Serum 25(OH)-VitD3 analysis
At baseline, 25(OH)-VitD3 was measured in serum during visits to the Department of Paediatrics and Adolescent Medicine of the Friedrich-Alexander Universit€ at Erlangen-N€ urnberg (Erlangen, Germany) using a liquid chromatography-tandem mass spectrometry (LC-MS/MS) MassChrom Kit from Chromsystems Instruments and Chemicals GmbH (Gr€ afelfing, Germany), according to the manufacturer's protocol.
Isolation of peripheral blood mononuclear cells (PBMCs) from children with and without asthma and RV infection of PBMCs
PBMCs were isolated from heparinized blood with Ficoll using density centrifugation at the time of recruitment (baseline 0) (B0 5 day 0) and 2 years later at a follow-up visit 4 (F4). PBMCs were then adjusted to a concentration of 1 3 10 6 viable cells/ml in complete culture medium, as described previously, and parts of them were challenged invitro or not with RV (RV1b) and were cultured for an additional 48 h to perform RNA gene array assays and further analyses. The growth of RV1b and the description of the RV1b infection itself have been published previously in detail elsewhere [27] .
Gene arrays
To analyse RNA from PBMCs at F4, we performed gene arrays. RNA was reverse-transcribed after passing high stringency quality controls. Biotinylated cDNA was prepared according to the standard Illumina protocol from 13Á9 ng total RNA using an amplification kit Pico WTA (NuGen Technologies, Inc., Leek, the Netherlands; lot no. 1404311-A/C), followed by labelling 3 mg cDNA using an Encore Biotin IL module kit (NuGen; lot no. 1212262-D). Bead chips were scanned using the Illumina iScan scanner (Eindhoven, the Netherlands) running Illumina iSCAN control software version 3Á3Á28. Illumina Genome-Studio version 2011 was used to analyse the data. Heatmaps were generated by performing supervised clustering on normalized expression data using R version 3Á1 and library gplots. In the gene array cultured experiments, cells from five control and seven asthmatic children who were exposed or not to RV1b for 1 h were analysed. Genes related to ILC2 were selected, and the results were reported as log 2 ratio (average signal treated/average signal untreated samples) of statistically significantly regulated genes, P 0Á01.
RV detection in vivo
The detection of RV in nasopharyngeal swabs from the children was performed at the Department of Virology, University of Turku (Finland). The description of this method was recently published in detail elsewhere [27] . 
Enzyme-linked immunosorbent assay (ELISA)
Forced expiratory volume in 1 s (FEV 1 )
FEV 1 and FVC (forced vital capacity) were measured at the baseline visit (B0) using spirometry. After a period of normal breathing the participant should inhale at maximal capacity, followed directly by maximal and fast exhalation. The volume exhaled in 1 s is FEV 1 . The total exhaled volume is FVC. The ratio of FEV 1 /FVC is reported as FEV 1 %.
Statistical analysis
Differences were evaluated for significance (*P 0Á05; ** P 0Á01, ***P 0Á001) using parametric two-tailed Student's t-tests (Prism version 7 for Windows; GraphPad, La Jolla, CA, USA), unless stated otherwise. Data are shown as the mean values 6 standard error of the mean (s.e.m.). To examine the correlation of two parameters, GraphPad Prism software (version 7 for Windows) was used.
Results
Clinical characteristics of the cohorts of children analysed in this study
In this study, we analysed 22 control children and 24 preschool children with asthma. The clinical data of these cohorts of preschool children are reported in Table 1 . The average age of controls and children with asthma was 4Á7 and 4Á9 years, respectively. According to the guidelines, 62Á5% of the children had intermittent, 29Á2% mild-persistent and 8Á3% moderate-persistent asthma. Moreover, 72Á7% of controls and only 45Á8% of the children with asthma had an FEV 1 above 100% (Table 1 ). In 70Á8% of the cases, viral infection was a triggering factor for the development of the disease. RV was the most common respiratory virus detected in the airways of these children.
Gene arrays from in-vitro RV-infected PBMCs from preschool children with asthma revealed the induction of ILC2-associated genes
Innate lymphoid cells (ILCs) are detected frequently in the lung, although they originate from the bone marrow [11] . Thus, we reasoned that blood-circulating ILC2 progenitors might be present in the PBMCs of children with asthma. To investigate the relationship between circulating ILC2 and RV, we analysed RNA isolated from PBMCs from preschool children with and without asthma who were recruited in the European study Predicta in Erlangen (WP1-UKER), and cultured the cells for 48 h after a 1-h exposure in vitro to RV1b, as described previously [24, 25, 27] . After RNA extraction and RNA quality selection for gene arrays, the mRNA from seven children with asthma and five control children were analysed for gene arrays, as shown in Fig. 1a . We then selected genes related to the ILC2 pathway that showed a statistically significant RV-dependent up-regulation in PBMCs from asthmatic children. As a control, to create the heatmap we inserted some related genes that were down-regulated by the RV. We found that several genes inducing ILC2 activation, such as IL-25 [11] , IL-2RA [7] and IL-7 [7, 28] , and transmembrane emp24 domaincontaining protein 1 (TMED1) (IL-1RL-1) were upregulated by RV in PBMCs of asthmatic children ( Fig. 1b and Supporting information, Table S1 ). Moreover, we found increased expression of TNF-a, a gene stimulated by IL-33 [29] , and IL-1B, a gene involved in the activation of IL-33 [30] . Finally, we found that RV induced genes that are targets of 25(OH)-VitD3, such as amphiregulin, a gene that interacts with EGR [9, 31] , and promotes the growth of normal epithelial cells after cell damage. In contrast, lactadherin (Mfge8), which is involved in IL-33 signalling, was found to be down-regulated by RV in asthma [32] .
In summary, the genes up-regulated in PBMCs by RV in this paediatric cohort of asthmatic cases suggest an activation of ILC2 development and a down-regulation of genes that cut the viral RNA, such as RNAse1.
Furthermore, we analysed which genes were regulated by RV in PBMCs isolated from control children. We found an RV-induced up-regulation of EGR1, a receptor for amphiregulin [31] , in PBMCs. Moreover, NFKB inhibitor-a (NFKBIA) (also known as hepatic IjBa) is increased by RV. This gene plays an important role in persistent inflammation, and its decrease is associated with 25(OH)-VitD3 deficiency [33] . Conversely, retinoid X receptor b (RXRB), which forms a complex with the VitD receptor (VDR) and would be necessary to activate VDR targets [34] , is decreased in the PBMCs of control children by RV. In summary, in PBMCs isolated from control children, RV induces genes that are associated with epithelial damage and chronic inflammation. We next looked at RV in the nasal pharyngeal fluid and 25(OH)-VitD3 in the serum of these children. As shown below the heatmap, the majority of the asthmatic children analysed had low serum levels of 25(OH)-VitD3 and few had RV in the airways (Fig. 1b) . By contrast, control children had high (h) serum levels of 25(OH)-VitD3 and, like asthmatic children, generally did not have RV in their airways (Fig. 1c) . We next confirmed the gene array results by measuring TNF-a in the supernatants of the PBMCs using ELISA and found that PBMCs from asthmatic children released increased levels of TNF-a after RV exposure in vitro (Fig. 1f) . RT-PCR showed an up-regulation of ST2 in PBMCs isolated from asthmatic children after in-vitro exposure to RV (Fig. 1g) .
Reduced IFN-b levels in serum and increased ST2 mRNA levels in the blood cells of preschool children with asthma compared to control preschool children
To investigate further the role of in-vivo RV infection on ILC2, we first looked at IFN-b, an anti-viral gene regulated by RV and deficient in the airways of asthmatic subjects [35] , that was found recently to counter-regulate ILC2 [36] . IFN-b was found to be down-regulated, although not statistically significantly, in the serum of asthmatic preschool children compared to control children (Fig. 2a) . Consistent with the up-regulation of the ILC2-associated genes after RV challenge, in a larger cohort of preschool children with asthma we found induction of the ILC2-associated marker ST2 mRNA in the blood of these preschool children with asthma compared to control children (Fig. 2b) . Because ST2 is present in two different spliced variants, we used one set of primers recognizing the total transcript of ST2 (IL1RL1) (Fig. 2b) and an ELISA kit recognizing the soluble sST2 (Fig. 2c,d ) protein. No difference in sST2 was observed in serum (Fig. 2c) .
Increased sST2 protein in the nasopharyngeal fluid (NPF) of preschool children with asthma with RV in the airways
We next wanted to analyse sST2 protein at baseline in the NPF of the two cohorts of children. We found that the asthmatic children had more sST2 in the airways compared to the control children (Fig. 2d) . In addition, we found that in serum there is 100 times more sST2 compared to that in the upper airways, indicating that the majority of sST2 is produced by blood cells. These results support the notion that sST2-producing cells are circulating cells rather than cells present in the airways.
Regulation of ST2 by RV in the airways of asthmatic children
We next considered the presence of RV in the airways in the pathway analysed above. In the presence of RV in the airways in control children, IFN-b was found to be downregulated in serum whereas, independently from RV, IFN-b was always low in the serum from asthmatic children (Fig.  3a) . AREG mRNA was found up-regulated in mRNA isolated from total blood cells of control children when RV was detected in their airways (Fig. 3b) . Moreover, in the absence of RV in the airways, ST2 mRNA was found upregulated in blood cells from asthmatic children compared to control children without RV in the airways (Fig. 3c) .
These data suggest an ST2 induction associated with factors other than RV.
We then analysed sST2 protein levels in the serum and NPF considering that RV is present in the airways of these cohorts of preschool children. Although no statistically significant difference was found, as a trend, sST2 protein was reduced in serum and induced in NPF of asthmatic children with RV in their airways (Fig. 3d,e, respectively) . These data indicate that sST2 is induced/recruited in the airways of asthmatic children by RV, indicating a role of sST2 in anti-viral immune responses in the presence of RV in the airways in asthma. sST2 in serum is correlated directly with IL-33 in the nasopharyngeal fluid of asthmatic children Because sST2 neutralizes IL-33, which we found recently induced in the airways of asthmatic children with Gramnegative bacteria colonization, we next asked if there was a correlation between sST2 and IL-33 in the airways. We found that serum sST2 protein correlated directly with IL-33 in the airways of asthmatic but not in the airways of control children (Fig. 4a,b) . No significant correlations were found by comparing IL-33 and sST2 protein in NPF (Fig. 4c,d ).
VitD3 supplementation and 25(OH)-VitD3 in the serum of asthmatic children
We reasoned further that many genes we found activated by RV were genes that were down-regulated by 25(OH)-VitD3, which has a protective role in asthma exacerbations [37] .
In Germany, VitD3 is given to infants [38] to avoid immunological suppression, especially in children who did not receive breastfeeding. By analysing the potential effect of this VitD3 supplementation, we analysed the questionnaire completed by the parents/guardians. Here we noted that the percentage of children treated with VitD3 supplement (Fluorette: Colecalciferol and fluorid) was higher in the control group compared to the asthma group (Table 1) . We next analysed the role of cholecalciferol, VitD3, supplementation during infancy on serum 25(OH)-VitD3 levels in our cohort of children with or without asthma. By considering 0 as no VitD3 supplement and 1 as VitD3 supplement taken as an infant, we found that, in contrast to control children (Supporting information, Fig. S1a and Table S2 ), in asthmatic children increased serum 25(OH)-VitD3 correlated with having taken a VitD3 supplement during infancy (Supporting information, Fig. S1b ). Seventy-five per cent of asthmatic children and 50% of control children with VitD3 supplement had high 25(OH)-VitD3 serum levels at the time of recruitment (Supporting information, Table S2 ). Taken together, these data indicate a strong association between asthma development in childhood, insufficient 25(OH)-VitD3 in serum and the lack of VitD3 supplementation as an infant.
Symptomatic asthma exacerbations are associated with increased 25(OH)-VitD3 in serum of asthmatic children
Wheezing is associated with asthma during the first years of life [39] . Moreover, RV is the factor that is associated with wheezing in infants [40] . Further, the levels of 25(OH)-VitD3 in serum, considering the presence of RV in the airways, was found down-regulated in the serum of control children with RV in their airways and in asthmatic children without RV in their airways (Fig. 5a) . Moreover, 25(OH)-VitD3 was found to be induced in the serum of children during asthma exacerbation when, as we have reported previously, RV was present in the airways (Fig.  5b) . Altogether, these data indicate a role of the serum level of 25(OH)-VitD3 in RV-induced asthma development.
VDR is induced by RV and serum 25(OH)-VitD3 levels in control children
We next looked for an explanation of why 25(OH)-VitD3 serum levels decreased in serum of control children when RV was detected in their airway. As first, we thought that the host would react to RV by transporting the 25(OH)-VitD3 from blood fluid into blood cells. To prove this, we analysed VitD3 receptor (VDR) expression in total blood cells. We found a significant increase in VDR mRNA in control children with RV in the airways compared to control children without RV in the airways (Fig. 5c) . The same trend was observed for VDR in asthmatic children, although not significant. We then questioned if VDR expression would also be influenced by serum levels of 25(OH)-VitD3; we observed a significant induction of VDR in control children with RV and high serum levels of 25(OH)-VitD3 (Fig. 5d) . In asthmatic children we did not have the group with high 25(OH)-VitD3 without RV, and therefore we cannot draw any conclusions. Further extended analyses are required.
IL-33 in the airways correlated directly with 25(OH) in serum in asthma
We then wanted to investigate the role of 25(OH)-VitD3 and the IL-33/ST2 pathway. Here, we started by examining the correlation between 25(OH)-VitD3 in serum and IL-33 in the NPF. We found that IL-33 in the NPF was correlated directly with serum 25(OH)-VitD3 in asthmatic children (Fig. 6a,b) at baseline. This result is in agreement with our previous finding, that sST2 correlated directly with IL-33, and with the finding that 25(OH)-VitD3 induces sST2.
Low 25(OH)-VitD3 [ low 25(OH)-VitD3] levels are associated with lower IFN-b levels in serum and high AREG in blood cells in asthmatic children
We next questioned whether IFN-b was regulated in children with higher levels of 25(OH)-VitD3 (Fig. 7a) . We found that control children with higher serum 25(OH)-VitD3 levels (higher than 20 ng/ml) had higher serum IFNb levels, although this difference was not statistically significant (Fig. 7a) ; asthmatic children always had lower serum levels of IFN-b irrespective of their serum of 25(OH)-VitD3 levels (Fig. 7a) .
As IFN-beta limits ILC2 activation, we then analysed AREGB mRNA considering the influence of 25(OH)-VitD3 and found that, consistent with an increase in IFN-beta, higher serum levels of 25(OH)VitD3 were associated with the down-regulation of AREGB mRNA in blood cells of control children (Fig. 7b) . By contrast, asthmatic children did not down-regulate AREGB when 25(OH)-VitD3 was increased (Fig. 7b) , and at low levels of 25(OH)-VitD3 they had lower AREG compared to the control children, with lower 25(OH)-VitD3 (Fig. 7b) . We next considered the presence of RV in the airways and found that IFN-beta induction was associated with high 25(OH)-VitD3 serum levels in control children in the absence of RV in the airways (Fig. 7c) . In control children AREG was found to be up-regulated by RV and low serum 25(OH)-VitD3 levels (Fig. 7d) .
ST2 mRNA is induced in blood cells of asthmatic children with low 25(OH)-VitD3 serum levels without RV
We next examined the relationship between ST2 mRNA in blood cells and 25(OH)-VitD3 in serum. We found that asthmatic children with low serum levels of 25(OH)-VitD3 had significantly higher levels of ST2 mRNA (Fig. 8a) compared to the control children with comparable low serum levels of 25(OH)-VitD3. By considering the presence of RV in the airways we could confirm the findings that higher ST2 mRNA levels were not associated with the presence of RV in vivo but with lower 25(OH)-VitD3 serum levels. Reconsidering serum 25(OH)-VitD3 levels of the children analysed in the gene arrays, we found that the asthmatic children all had lower levels of serum 25(OH)-VitD3 (Table  2 and number of the children below the heatmaps), whereas the control children had relatively higher serum 25(OH)-VitD3 levels. In conclusion, we found that the level of 25(OH)-VitD3 and not RV in the airways is probably the cause of ST2 induction after in-vitro exposure to RV in PBMCs.
sST2 in serum was reduced by RV in vivo in control and in asthmatic children
It has been demonstrated recently that 25(OH)-VitD3 enhances production of the soluble ST2 isoform [16] .
Soluble ST2, as mentioned above, is an antiinflammatory marker capable of neutralizing IL-33, the inflammatory cytokine also known as the ligand of ST2. Considering the anti-inflammatory function of 25(OH)-VitD3, we next questioned the relationship between 25(OH)-VitD3 RV in the airways and sST2. We found that the highest levels of the anti-inflammatory isoform sST2 were present in the serum of control children with high levels of 25(OH)-VitD3 and without RV in the airways ( 8c,d). The presence of RV in the airways was the cause of sST2 reduction both in control and in asthmatic children. The latter, also associated with low levels of 25(OH)-VitD3, contributed with RV to the reduction of the sST2 in serum.
In conclusion, we found that ST2 is up-regulated in blood cells of asthmatic children not by RV, but by low levels of serum levels of 25(OH)-VitD3. By contrast, the antiinflammatory sST2 isoform was found down-regulated by RV and also in asthma by combined low levels of 25(OH)-VitD3.
Discussion
We found that RV challenge in the airways, which is one of the main factors in asthma exacerbations [41, 42] , is associated with reduced expression of the anti-inflammatory protein sST2 in the blood cells of children with and without asthma. Moreover, we found that the soluble form of ST2, sST2, was down-regulated in the serum of asthmatic children with RV in the airways and with low serum levels of 25(OH)-VitD3. 25(OH)-VitD3 deficiency has been associated with asthma, as in many inflammatory and autoimmune pathologies [43, 44] . The highest levels of serum sST2 were observed in the serum of control children without RV in the airways and high serum levels of 25(OH)-VitD3. Previous studies have shown that ST2 plays an important role in ILC2-driven allergic asthma [45] and that RV can induce type 2-and ILC2-associated cytokines [12] . In addition, the role of sST2 was reported previously in the literature of asthmatics in induced sputum [46] . In this study we first observed, by gene arrays in the peripheral blood of preschool children with asthma, an increased expression of ILC2-related markers such as AREG, and confirmed this finding by correlating with the clinical outcomes of these children. Total ST2 mRNA was found up-regulated after in-vitro exposure to RV and in the blood of asthmatic children with low serum levels of 25(OH)-VitD3 without RV in their airways. sST2 is the ligand of IL-33, and because it is soluble it can circulate and reach the airways where IL-33 is released. IL-33 has also been described to regulate sST2 [47] . Moreover, IL-33 and its receptor and sST2 were investigated largely in asthmatic children [48, 49] . We thus examined the correlation of IL-33 in the airways with sST2. We found that the serum levels of sST2 correlated directly with IL-33 in the airways in asthmatic children. Also, serum levels of 25(OH)-VitD3 correlated directly with serum sST2 and IL-33 in the airways of asthmatic children. Asthmatic children who did not receive VitD3 supplementation as infants had more episodes of asthma exacerbation and those who had RV in vivo in their airways at the time of the analysis had reduced serum 25(OH)-VitD3 levels associated with less sST2 serum levels and with lower AREG (a protein involved in epithelial cell repair) protein levels in the peripheral blood.
RV infection can damage epithelial cells [50] and delay epithelial cell repair [51] .
Several studies have shown that 25(OH)-VitD3 has the potential to prevent the development of allergic asthma [52, 53] and even has the ability to reduce asthma exacerbations [54] , so we investigated further its influence on RVinduced allergic asthma in preschool children.
RV challenge in the airways is one of the main factors inducing asthma exacerbations [41] . Previous studies have shown that ST2 plays an important role in ILC2-driven allergic asthma [45] and that RV can induce type 2-and ILC2-associated cytokines [12] . As little is known about how this new cell type can be influenced exogenously, we chose to focus upon the impact of 25(OH)-VitD3 on ST2-driven allergic asthma.
We first found increased ILC2 cell-related markers in the peripheral blood from asthmatic children after RV challenge, in accordance with the results of former studies [12] .
By following-up this finding we found that AREG is induced, whereas IFN-b, an anti-viral IFN that has been discovered recently to inhibit ILC2s, is decreased in the blood of asthmatic children [36] . We subgrouped the children further by the presence of RV in their airways in vivo and found that, in the absence of RV in the airways, IFN-b serum levels of asthmatic children were decreased. We subgrouped the children further according to their serum levels of 25(OH)-VitD3 and found that only control children with high 25(OH)-VitD3 serum levels could produce higher amounts of IFN-b. In conclusion, IFN-b is induced by high levels of 25(OH)-VitD3 in control children and was found to be reduced in asthma.
To investigate which mechanism is activated by 25(OH)-VitD3 in IFN-b induction, we examined ILC2 markers that have inhibitory functions on IFN-b production. We found that AREGB, which encodes amphiregulin, a protein that promotes the growth and repair of normal epithelial cells in the airways, was found to be induced by in-vivo RV infection in control children. This up-regulation of AREGB may be activated because of the damage that RV causes to the epithelial cells [50] in vivo and, as a result, it contributes to epithelial cell repair [51] . We next considered the effect of the serum level of 25(OH)-VitD3 on AREG mRNA levels in blood and found that it was downregulated when higher serum levels of 25(OH)-VitD3 in control children were measured. In contrast, higher serum Table 2 . Analysed data of children at baseline visit Virus swab* 25(OH)-VitD3 † levels of 25(OH)-VitD3 were found to be associated with higher IFN-b levels in control children. Thus, AREGB is an ILC2 marker that could be considered as a limiting factor, possibly limiting IFN-b production upon RV infection in control preschool children. We next examined ST2 and sST2, which we found upregulated in asthmatic children. ST2 was found to be upregulated in the blood cells of asthmatic children. Considering the presence of RV in the airways, we found a significant induction of ST2 mRNA expression in the blood cells of asthmatic children without RV colonization in the airways. Considering serum levels of 25(OH)-VitD3, ST2 mRNA was found to be up-regulated in blood cells of asthmatic children with lower levels of 25(OH)VitD3 without RV in the airways. RV in the airways reduced ST2 mRNA. Additional factors could be responsible for the ST2 induction in the absence of RV in the airways in asthmatic children. One possibility is the decrease in IFN-b production in this group. Moreover, we reported recently that the bacterial colonization of the airways of these children influences ST2. In fact, ST2 was found to be up-regulated in asthmatic children with a mixed Gram-positive and Gramnegative bacterial colonization in their airways [25] . Finally, high 25(OH)-VitD3 serum levels were found to be associated with higher anti-inflammatory sST2 in control children without RV in the airways. The presence of RV in vivo both in control and asthmatic children was associated with decreased sST2 serum levels although, in asthmatic children, it was observed at low levels of serum 25(OH)-VitD3 and in control children at high levels of serum 25(OH)-VitD3. Thus, it is possible that the downregulation of ST2 mRNA observed after RV in asthma relates to sST2.
In summary, low levels of 25(OH)-VitD3 without RV induced ST2 and low levels of 25(OH)-VitD3 with RV reduced sST2. These results explain the apparent discrepancy of the gene arrays which do not recognize the soluble form of ST2.
When we examined the asthmatic exacerbations, we found them induced in asthmatic children without VitD3 supplement as infants. Moreover, at the symptomatic visit, a condition always associated with RV in the airways of these children, we found increased serum levels of 25(OH)-VitD3. By looking at control children, RV in the airways was always associated with decreased serum level of 25(OH)-VitD3, thus suggesting a dysregulation of this system. By looking at the intracellular carrier for 25(OH)-VitD3, the VitD3 receptor (VDR), we found it upregulated in control children with RV in the airways and with high levels of serum 25(OH)-VitD3. This mechanism seems to make sense as a transport mechanism induced upon 25(OH)-VitD3 induction. It remains to be explained why, during symptomatic visits with RV in the airways, asthmatic children have higher serum 25(OH)-VitD3 levels. One possibility is that in asthmatic children this carrier mechanism is dysregulated.
In conclusion, we suggest that in control children with RV infection 25(OH)-VitD3 is carried intracellularly, where it binds to the VDR. These data are supported by our VDR expression data showing induction of VDR after RV and at high serum levels of 25(OH)-VitD3 in control children.
Next, we questioned if there was a relevant influence from factors present in the infancy of the children in our cohort that could have affected their current status of serum 25(OH)-VitD3 and the development of allergic diseases. Former studies have shown that lower 25(OH)-VitD3 intake increased the risk of developing allergic asthma [55] . Children with asthma who did not receive VitD3 supplements as infants, as reported by their parents, had lower serum 25(OH)-VitD3 levels.
We analysed further which parameters may have been influenced by the current 25(OH)-VitD3 serum levels of the children. High 25(OH)-VitD3 serum levels were found to be associated with an induction of IFN-b in the serum of control children, which might indicate a possible synergetic effect of 1a, 25(OH)2-VitD3 and IFN-b. By contrast, in asthmatic children, even high 25(OH)-VitD3 levels could not induce any anti-microbial IFN-b-mediated immune response, confirming a defect of IFN-b in the serum of asthmatic children.
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